European Commission's Failure to Determine Whether Originator "Tool-Boxes" Are Appropriate Responses to Generic "Tool-Boxes," or Abuses Under Article 82 EC
IN 2008 AND 2009, the European Commission conducted its Pharmaceutical Sector Inquiry based on a suspicion that a slower rate of approval for new drugs may have resulted from violations of European Union competition law. The Commission issued Preliminary and Final Reports detailing the findings of the Inquiry, which did not include any findings of the sort of competition law violations originally
